AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing ...

AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics (Cyncado), today issued a recap of data presented on ...

AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4’s Path to First- Patient Dosing

AlphaTON Capital Corp ( Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, today announced that a new poster is live at the AACR ...
Lodi News-Sentinel

openvela's Inaugural Global Developer Conference Concludes Successfully, NuttX Founder Gregory Nutt Joins to Shape AIoT Ecosystem

SAN JOSÉ, Costa Rica , Oct. 25, 2025 /PRNewswire/ -- openvela's first Global Developer Conference has wrapped up successfully ...
Oswego County Today

Fairley fourth graders explore shoreline, trails at Camp Hollis

OSWEGO – Fairley Elementary School fourth-grade students recently embarked on an outdoor learning adventure at Camp Hollis, where they explored the natural world along the Lake Ontario ...
Center for American Progress

How Changes to Fourth-Grade Reading Standards and Research-Backed Approaches Can Improve Reading Achievement

Alabama, Louisiana, Massachusetts, and Mississippi—have shown that adopting more rigorous literacy standards and scientific ...
TMCnet

AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth

As described in the abstract, investigators will present first evidence that A2B receptor inhibition reduces the adenosine-mediated increase in PD-L1 in a human epithelioid mesothelioma cell line, ...